FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
News|Slideshows|October 10, 2023
IDWeek 2023 Features Leaders Spanning the Specialty's Expertise
Author(s)Grace Halsey
Advertisement
IDWeek 2023 plenary sessions and named lectures will cover topics ranging from a 20-year history of antibiotic stewardship and the current state of inequities in stewardship and infection control to role of artificial intelligence in the future of infectious disease.
Experts from leading US academic medical centers and esteemed colleagues who will serve as session moderators will focus on some of the most vexing issues facing the practice of infectious disease as well as potential bright spots and solutions. Click through the slides here for an introduction to these top thinkers and the title, day, and time of their sessions.
Advertisement
Related to this article
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
2
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
5